DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lencioni R, Venook AP, Marrero JA , et al.
Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study - Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis. Abs 6500.
Abstract presented at: The European Multidisciplinary Cancer Congress; September 23–27, 2011; Stockholm, Sweden
We do not assume any responsibility for the contents of the web pages of other providers.